EP4137512 - ANTI-GM2AP ANTIBODY AND APPLICATIONS THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.08.2023 Database last updated on 06.11.2024 | |
Former | The application has been published Status updated on 20.01.2023 | Most recent event Tooltip | 26.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Vitae Biomedical., Co., Ltd. Rm. 614, 6F., Building C, Nº, 99 Ln. 130, Sec. 1, Academia Rd. Nangang Dist. Tapei City 115 / TW | For all designated states Taiwan Innovative Integration Services Co., Ltd. 11F., Nº. 95, Sec. 2, Nanjing E. Rd. Zhongshan Dist. Taipei City 104 / TW | [2023/08] | Inventor(s) | 01 /
CHEN, Shui-Tein 115 Taipei City / TW | [2023/08] | Representative(s) | Dörries, Hans Ulrich df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16 80333 München / DE | [2023/08] | Application number, filing date | 22190485.7 | 16.08.2022 | [2023/08] | Priority number, date | TW20210130070 | 16.08.2021 Original published format: TW 110130070 | [2023/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4137512 | Date: | 22.02.2023 | Language: | EN | [2023/08] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.01.2023 | Classification | IPC: | C07K16/18 | [2023/08] | CPC: |
C07K16/18 (EP,KR);
G01N33/68 (KR);
C07K2317/21 (KR);
C07K2317/92 (EP,KR)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/38] |
Former [2023/08] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTI-GM2AP-ANTIKÖRPER UND ANWENDUNGEN DAVON | [2023/08] | English: | ANTI-GM2AP ANTIBODY AND APPLICATIONS THEREOF | [2023/08] | French: | ANTICORPS ANTI-GM2AP ET APPLICATIONS ASSOCIÉES | [2023/08] | Examination procedure | 11.08.2023 | Amendment by applicant (claims and/or description) | 11.08.2023 | Examination requested [2023/38] | 11.08.2023 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 26.08.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]US7510843 (ROECKLIN DOMINIQUE [FR], et al); |